Vericel Corp Uncategorized Contracts & Agreements

38 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fourth Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated June 1, 2024
Vericel Corp
Biotechnology
2024
Third Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated May 16, 2022
Vericel Corp
Biotechnology
2022
First Amendment to Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated May 1, 2019
Vericel Corp
Biotechnology
2019
Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated July 26, 2018
Vericel Corp
Biotechnology
2018
Amendment No. 5 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated December 5, 2017
Vericel Corp
Biotechnology
2017
Amendment No. 4 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated November 9, 2017
Vericel Corp
Biotechnology
2017
Amendment No. 3 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated October 9, 2017
Vericel Corp
Biotechnology
2017
Amendment No. 2 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated September 5, 2017
Vericel Corp
Biotechnology
2017
Amendment No. 1 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated August 3, 1017
Vericel Corp
Biotechnology
2017
* * * * *
Vericel Corp
Biotechnology
NY
2017
CONFIDENTIAL AND PROPRIETARY TO PPD
Vericel Corp
Biotechnology
2016
64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION Table of Contents
Vericel Corp
Biotechnology
2016
64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION TABLE OF CONTENTS
Vericel Corp
Biotechnology
2016
RESIGNATION AGREEMENT
Vericel Corp
Biotechnology
MI
2013
CONFIDENTIAL AND PROPRIETARY TO [ * * * ]
Vericel Corp
Biotechnology
2011
AASTROM BIOSCIENCES, INC.
Vericel Corp
Biotechnology
NY
2011
AASTROM BIOSCIENCES, INC.
Vericel Corp
Biotechnology
MI
2010
BYLAWS OF AASTROM BIOSCIENCES, INC.
Vericel Corp
Biotechnology
2008
CURRENT ASSETS
Vericel Corp
Biotechnology
2008
AGREED AND ACCEPTED: Name of Investor: Name Title: Address: DWAC Number: AASTROM BIOSCIENCES, INC. By: Name: Title:
Vericel Corp
Biotechnology
NY
2007
CURRENT ASSETS
Vericel Corp
Biotechnology
2007
CURRENT ASSETS
Vericel Corp
Biotechnology
MI
2006
CURRENT ASSETS
Vericel Corp
Biotechnology
MI
2006
Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction
Vericel Corp
Biotechnology
2005
Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction
Vericel Corp
Biotechnology
MI
2005
Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction
Vericel Corp
Biotechnology
2005
Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction
Vericel Corp
Biotechnology
MI
2005
CURRENT ASSETS
Vericel Corp
Biotechnology
MI
2004
CURRENT ASSETS
Vericel Corp
Biotechnology
2004
Local bone regeneration in fractures, spinal fusion and jaw bone reconstruction for dental implants
Vericel Corp
Biotechnology
NY
2004
Engagement Agreement dated March 19, 2004 by and between the Company and Jesup & Lamont Securities Corporation
Vericel Corp
Biotechnology
2004
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
MI
2003
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
2003
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
2003
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
2003
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
2002
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
2002
LEGAL PROCEEDINGS
Vericel Corp
Biotechnology
2002